Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

Author： Land Stephanie   Kopec Jacek   Yothers Greg   Anderson Stewart   Day Richard   Tang Gong   Ganz Patricia   Fisher Bernard   Wolmark Norman  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.86, Iss.2, 2004-07, pp. : 153-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

By Amadori Dino   Silvestrini Rosella   Lena Mario   Boccardo Francesco   Rocca Andrea   Scarpi Emanuela   Schittulli Francesco   Brandi Mario   Maltoni Roberta   Serra Patrizia   Ponzone Riccardo   Biglia Nicoletta   Gianni Lorenzo   Tienghi Amelia   Valerio Maria   Bonginelli Paola   Amaducci Laura   Faedi Marina   Baldini Editta   Paradiso Angelo  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 775-784

Springer Publishing Company

Access to resources Recommend Favorite

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

By Dignam James   Wieand Kelly   Johnson Karen   Raich Peter   Anderson Stewart   Somkin Carol   Wickerham D.  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 245-254

Springer Publishing Company

Access to resources Recommend Favorite

Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

By              

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 303-308

Spandidos Publications

Access to resources Recommend Favorite

Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy, by Dengel et al.

By Boughey Judy  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 8-10

Springer Publishing Company

Access to resources Recommend Favorite

Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy

By Dengel Lynn   Zee Kimberly   King Tari   Stempel Michelle   Cody Hiram   El-Tamer Mahmoud   Gemignani Mary   Sclafani Lisa   Sacchini Virgilio   Heerdt Alexandra   Plitas George   Junqueira Manuela   Capko Deborah   Patil Sujata   Morrow Monica  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 22-27

Springer Publishing Company

Access to resources Recommend Favorite